ATP-loaded immunoliposomes specific for cardiac myosin provide improved protection of the mechanical functions of myocardium from global ischemia in an isolated rat heart model

References

• Blume G, Cevc G. Liposomes for the sustained drug release in vivo. Biochim Biophys Acta 1990; 1029(1)91–97
   PubMed Web of Science ®Google Scholar
• Flameng W. New strategies for intraoperative myocardial protection. Curr Opin Cardiol 1995; 10(6)577–583
   PubMed Web of Science ®Google Scholar
• Hearse DJ, Garlick PB, Humphrey SM. Ischemic contracture of the myocardium: Mechanisms and prevention. Am J Cardiol 1977; 39(7)986–993
   PubMed Web of Science ®Google Scholar
• Jennings RB, Schaper J, Hill ML, Steenbergen C, Jr, Reimer KA. Effect of reperfusion late in the phase of reversible ischemic injury. Changes in cell volume, electrolytes, metabolites, and ultrastructure. Circ Res 1985; 56(2)262–278
   PubMed Web of Science ®Google Scholar
• Khaw BA, Beller GA, Haber E, Smith TW. Localization of cardiac myosin-specific antibody in myocardial infarction. J Clin Invest 1976; 58(2)439–446
   PubMed Web of Science ®Google Scholar
• Khaw BA, Fallon JT, Beller GA, Haber E. Specificity of localization of myosin-specific antibody fragments in experimental myocardial infarction. Histologic, histochemical, autoradiographic and scintigraphic studies. Circulation 1979; 60(7)1527–1531
   PubMed Web of Science ®Google Scholar
• Khaw BA, Scott J, Fallon JT, Cahill SL, Haber E, Homcy C. Myocardial injury: Quantitation by cell sorting initiated with antimyosin fluorescent spheres. Science 1982; 217(4564)1050–1053
   PubMed Web of Science ®Google Scholar
• Khaw BA, Torchilin VP, Klibanov AL, Nossiff ND, Powers JB, Strauss HW, Haber E. Modification of monoclonal antimyosin antibody: Enhanced specificity of localization and scintigraphic visualization in acute experimental myocardial infarction. J Mol Cell Cardiol 1989; 21(Suppl 1)31–35
   PubMed Web of Science ®Google Scholar
• Khaw BA, Torchilin VP, Vural I, Narula J. Plug and seal: Prevention of hypoxic cardiocyte death by sealing membrane lesions with antimyosin–liposomes. Nat Med 1995; 1(11)1195–1198
   PubMed Web of Science ®Google Scholar
• Khaw BA, Yasuda T, Gold HK, Leinbach RC, Johns JA, Kanke M, Barlai-Kovach M, Strauss HW, Haber E. Acute myocardial infarct imaging with indium-111-labeled monoclonal antimyosin Fab. J Nucl Med 1987; 28(11)1671–1678
   PubMed Web of Science ®Google Scholar
• Khudairi T, Khaw BA. Preservation of ischemic myocardial function and integrity with targeted cytoskeleton-specific immunoliposomes. J Am Coll Cardiol 2004; 43(9)1683–1689
   PubMed Web of Science ®Google Scholar
• Klibanov AL, Maruyama K, Torchilin VP, Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 1990; 268(1)235–237
   PubMed Web of Science ®Google Scholar
• Kuzmin AI, Lakomkin VL, Kapelko VI, Vassort G. Interstitial ATP level and degradation in control and postmyocardial infarcted rats. Am J Physiol 1998; 275(3 Pt 1)C766–C771
   PubMed Web of Science ®Google Scholar
• Lasic DD, Martin F. Stealth liposomes1st ed. CRC Press, LLC, Boca Raton, FL 1995
   Google Scholar
• Liang W, Levchenko T, Khaw B, Torchilin V. ATP-containing immunoliposomes specific for cardiac myosin. Curr Drug Deliv 2004; 1: 1–7
   PubMedGoogle Scholar
• Liang W, Levchenko TS, Torchilin VP. Encapsulation of ATP into liposomes by different methods: Optimization of the procedure. J Microencapsul 2004; 21(3)251–261
   PubMed Web of Science ®Google Scholar
• Lukyanov AN, Hartner WC, Torchilin VP. Increased accumulation of PEG–PE micelles in the area of experimental myocardial infarction in rabbits. J Control Release 2004; 94(1)187–193
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release 2000; 65(1–2)271–284
   PubMed Web of Science ®Google Scholar
• Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 2001; 41: 189–207
   PubMedGoogle Scholar
• Nguyen PD, O'Rear EA, Johnson AE, Patterson E, Whitsett TL, Bhakta R. Accelerated thrombolysis and reperfusion in a canine model of myocardial infarction by liposomal encapsulation of streptokinase. Circ Res 1990; 66(3)875–878
   PubMed Web of Science ®Google Scholar
• Pick U. Liposomes with a large trapping capacity prepared by freezing and thawing of sonicated phospholipid mixtures. Arch Biochem Biophys 1981; 212(1)186–194
   PubMed Web of Science ®Google Scholar
• Reimer KA, Jennings RB. Myocardial ischemia, hypoxia, and infarction. The heart and cardiovascular system2nd ed., HA Fozzard, E Haber, RB Jennings. Raven Press, New York, NY 1992; 1875–1953
   Google Scholar
• Roberts R, Kleiman NS. Earlier diagnosis and treatment of acute myocardial infarction necessitates the need for a ‘new diagnostic mind-set’. Circulation 1994; 89(2)872–881
   PubMed Web of Science ®Google Scholar
• Torchilin VP, Khaw BA, Smirnov VN, Haber E. Preservation of antimyosin antibody activity after covalent coupling to liposomes. Biochem Biophys Res Commun 1979; 89(4)1114–1119
   PubMed Web of Science ®Google Scholar
• Torchilin VP, Levchenko TS, Lukyanov AN, Khaw BA, Klibanov AL, Rammohan R, Samokhin GP, Whiteman KR. p-Nitrophenylcarbonyl–PEG–PE–liposomes: Fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups. Biochim Biophys Acta 2001; 1511(2)397–411
   PubMed Web of Science ®Google Scholar
• Torchilin VP, Narula J, Halpern E, Khaw BA. Poly(ethylene glycol)-coated anti-cardiac myosin immunoliposomes: Factors influencing targeted accumulation in the infarcted myocardium. Biochim Biophys Acta 1996; 1279(1)75–83
   PubMed Web of Science ®Google Scholar
• Torchilin VP, Trubetskoy VS. Which polymers can make nanoparticulate drug carriers long-circulating?. Adv Drug Deliv Rev 1995; 16: 141–155
   Web of Science ®Google Scholar
• Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005; 4(2)145–160
   PubMed Web of Science ®Google Scholar
• Verma DD, Levchenko TS, Bernstein EA, Torchilin VP. ATP-loaded liposomes effectively protect mechanical functions of the myocardium from global ischemia in an isolated rat heart model. J Control Release 2005a; 108(2–3)460–471
   PubMed Web of Science ®Google Scholar
• Verma DD, Hartner WC, Levchenko TS, Bernstein EA, Torchilin VP. ATP-loaded liposomes effectively protect the myocardium in rabbits with an acute experimental myocardial infarction. Pharm Res 2005b, 22(12): 2115—2120
   PubMed Web of Science ®Google Scholar